_version_ 1784586122477699072
author Epaulard, Olivier
Buisson, Marlyse
Nemoz, Benjamin
Maréchal, Marion Le
Terzi, Nicolas
Payen, Jean-François
Froidure, Marie
Blanc, Myriam
Mounayar, Anne-Laure
Quénard, Fanny
Pierre, Isabelle
Pavese, Patricia
Germi, Raphaele
Grossi, Laurence
Larrat, Sylvie
Poignard, Pascal
Lupo, Julien
author_facet Epaulard, Olivier
Buisson, Marlyse
Nemoz, Benjamin
Maréchal, Marion Le
Terzi, Nicolas
Payen, Jean-François
Froidure, Marie
Blanc, Myriam
Mounayar, Anne-Laure
Quénard, Fanny
Pierre, Isabelle
Pavese, Patricia
Germi, Raphaele
Grossi, Laurence
Larrat, Sylvie
Poignard, Pascal
Lupo, Julien
author_sort Epaulard, Olivier
collection PubMed
description
format Online
Article
Text
id pubmed-8527702
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-85277022021-10-21 Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use Epaulard, Olivier Buisson, Marlyse Nemoz, Benjamin Maréchal, Marion Le Terzi, Nicolas Payen, Jean-François Froidure, Marie Blanc, Myriam Mounayar, Anne-Laure Quénard, Fanny Pierre, Isabelle Pavese, Patricia Germi, Raphaele Grossi, Laurence Larrat, Sylvie Poignard, Pascal Lupo, Julien J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-03 2021-10-20 /pmc/articles/PMC8527702/ /pubmed/34687831 http://dx.doi.org/10.1016/j.jinf.2021.10.009 Text en © 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Epaulard, Olivier
Buisson, Marlyse
Nemoz, Benjamin
Maréchal, Marion Le
Terzi, Nicolas
Payen, Jean-François
Froidure, Marie
Blanc, Myriam
Mounayar, Anne-Laure
Quénard, Fanny
Pierre, Isabelle
Pavese, Patricia
Germi, Raphaele
Grossi, Laurence
Larrat, Sylvie
Poignard, Pascal
Lupo, Julien
Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use
title Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use
title_full Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use
title_fullStr Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use
title_full_unstemmed Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use
title_short Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use
title_sort persistence at one year of neutralizing antibodies after sars-cov-2 infection: influence of initial severity and steroid use
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527702/
https://www.ncbi.nlm.nih.gov/pubmed/34687831
http://dx.doi.org/10.1016/j.jinf.2021.10.009
work_keys_str_mv AT epaulardolivier persistenceatoneyearofneutralizingantibodiesaftersarscov2infectioninfluenceofinitialseverityandsteroiduse
AT buissonmarlyse persistenceatoneyearofneutralizingantibodiesaftersarscov2infectioninfluenceofinitialseverityandsteroiduse
AT nemozbenjamin persistenceatoneyearofneutralizingantibodiesaftersarscov2infectioninfluenceofinitialseverityandsteroiduse
AT marechalmarionle persistenceatoneyearofneutralizingantibodiesaftersarscov2infectioninfluenceofinitialseverityandsteroiduse
AT terzinicolas persistenceatoneyearofneutralizingantibodiesaftersarscov2infectioninfluenceofinitialseverityandsteroiduse
AT payenjeanfrancois persistenceatoneyearofneutralizingantibodiesaftersarscov2infectioninfluenceofinitialseverityandsteroiduse
AT froiduremarie persistenceatoneyearofneutralizingantibodiesaftersarscov2infectioninfluenceofinitialseverityandsteroiduse
AT blancmyriam persistenceatoneyearofneutralizingantibodiesaftersarscov2infectioninfluenceofinitialseverityandsteroiduse
AT mounayarannelaure persistenceatoneyearofneutralizingantibodiesaftersarscov2infectioninfluenceofinitialseverityandsteroiduse
AT quenardfanny persistenceatoneyearofneutralizingantibodiesaftersarscov2infectioninfluenceofinitialseverityandsteroiduse
AT pierreisabelle persistenceatoneyearofneutralizingantibodiesaftersarscov2infectioninfluenceofinitialseverityandsteroiduse
AT pavesepatricia persistenceatoneyearofneutralizingantibodiesaftersarscov2infectioninfluenceofinitialseverityandsteroiduse
AT germiraphaele persistenceatoneyearofneutralizingantibodiesaftersarscov2infectioninfluenceofinitialseverityandsteroiduse
AT grossilaurence persistenceatoneyearofneutralizingantibodiesaftersarscov2infectioninfluenceofinitialseverityandsteroiduse
AT larratsylvie persistenceatoneyearofneutralizingantibodiesaftersarscov2infectioninfluenceofinitialseverityandsteroiduse
AT poignardpascal persistenceatoneyearofneutralizingantibodiesaftersarscov2infectioninfluenceofinitialseverityandsteroiduse
AT lupojulien persistenceatoneyearofneutralizingantibodiesaftersarscov2infectioninfluenceofinitialseverityandsteroiduse